Erik L. Ridley

Clinical News
Week in Review: John Henry Generation of radiologists? | Predicting prostate cancer progression | Tracking dementia patients
Our most popular story this week was the final article in a two-part series by radiologist Joshua Ewell, DO, on the future of AI and radiology.
January 17, 2025
Clinical News
Week in Review: Spike of PSMA-PET imaging | The challenge of ‘dysrhythmic’ radiologists | The last of the radiologists?
Two new columns and an analysis of the recent uptake in PSMA-PET imaging were among the most highly viewed articles this week on AuntMinnie.com.
January 10, 2025
Clinical News
Week in Review: Aetna sues Radiology Partners | Impact of USPSTF guidelines | Gender fraud case
Our first Week in Review of 2025 is headlined by our coverage of a lawsuit filed by Aetna against Radiology Partners.
January 3, 2025
Clinical News
Week in Review: CBD for breast cancer patients | Top 10 stories of 2024 | Response to Ra-223 therapy
The potential for CBD to lower clinical anxiety in breast care patients and our most popular stories of the year generated the most page views on AuntMinnie.com this week.
December 20, 2024
Clinical News
Missed aneurysm | CEO shooting suspect’s x-ray | AI predicts DCIS recurrence
Our top stories of the week included coverage of a complaint against a Florida radiologist and a spine x-ray of the UnitedHealthcare CEO shooter.
December 13, 2024
Clinical News
Top 25 articles from AuntMinnie.com’s RSNA 2024 RADcast
To celebrate our 25th anniversary, we’re sharing the top 25 most highly viewed articles from the conference in Chicago. Not surprisingly, AI figured prominently on the list.
December 9, 2024
Am Logo Main 25 Anniversary Thumbnail 66635a3c44252 66ae4e8a1f10e 6709a2db95b30
RSNA 2024
New PCCT scanners, Sequoia upgrade headline Siemens introductions at RSNA 2024
Siemens Healthineers
Siemens Healthineers spotlighted its new expanded photon-counting CT portfolio and the latest version of its Acuson Sequoia ultrasound scanner at RSNA 2024.
December 6, 2024
Naeotom Alpha is Siemens' new dual-source PCCT scanner. Image courtesy of Siemens Healthineers.
RSNA 2024
Canon features new MRI scanner, AI, CT enhancements at RSNA 2024
A new version of its 3-tesla MRI scanner, AI technologies, and CT technology improvements were among the highlights for Canon at RSNA 2024.
December 6, 2024
Canon's Galan 3T / Supreme Edition MRI scanner. Image courtesy of Canon Medical Systems.
RSNA 2024
Video from RSNA 2024: How rads can handle election results
In a wide-ranging interview, Saurabh Jha, MD, discusses his recent trip to Nepal, the controversy over whole-body MRI screening, and how radiologists can handle the recent presidential election results in the U.S.
December 5, 2024
2024 12 05 Saurabh Jha
Molecular Imaging
Video from RSNA 2024: Theranostics on the rise
In a video interview at RSNA, Eliot Siegel, MD, of the University of Maryland, discusses key trends and developments in the fast-moving field of theranostics.
December 4, 2024
2024 12 04 Siegel Eliot
Page 1 of 14
Next Page
Top Stories
Stroke Evt
Interventional
EVT promising in patients with extracranial ICA occlusions
Endovascular thrombectomy (EVT) and best medical treatment are both effective and safe options for patients with acute extracranial internal carotid artery occlusions.
Images depict a 49-year-old female participant with cryptogenic cirrhosis who presented with a 3.2-cm liver lesion. This biopsy-confirmed hepatocellular carcinoma (HCC) with an initial categorization of Liver Imaging Reporting and Data System (LI-RADS) category LR-4 (probably HCC) at CT was upgraded to LR-5 (definitely HCC) at contrast-enhanced ultrasound (CEUS). (A) Precontrast CT images in the liver show vague hypoattenuation in the medial left hepatic lobe (arrows). (B) Arterial phase images demonstrate no definite arterial phase hyperenhancement (arrows). (C) Washout and an enhancing capsule (arrows) on a late-phase image resulted in an LR-4 categorization. (D) B-mode ultrasound shows a round hypoechoic nodule (arrows). (E) An early-phase CEUS image shows clear arterial-phase hyperenhancement (arrows); (F) No washout at one minute (arrows), and (G) late, mild washout at four minutes (arrows) resulted in a CEUS LR-5 categorization.
Ultrasound
CEUS resolves indeterminate CT, MRI liver observations
Ctca
Molecular Imaging
PET/CT can rule out CAV in heart transplant patients
Lung Ct Images
CT
Machine learning can predict immunotherapy response in NSCLC patients
Coffta Sandy Thumbnail
Economics
Current topics in mammography
More in Home
EVT promising in patients with extracranial ICA occlusions
By Will Morton
Endovascular thrombectomy (EVT) and best medical treatment are both effective and safe options for patients with acute extracranial internal carotid artery occlusions.
January 21, 2025
Stroke Evt
CEUS resolves indeterminate CT, MRI liver observations
By Amerigo Allegretto
Contrast-enhanced ultrasound (CEUS) can resolve some high-risk indeterminate liver observations initially seen on CT or MRI.
January 21, 2025
Images depict a 49-year-old female participant with cryptogenic cirrhosis who presented with a 3.2-cm liver lesion. This biopsy-confirmed hepatocellular carcinoma (HCC) with an initial categorization of Liver Imaging Reporting and Data System (LI-RADS) category LR-4 (probably HCC) at CT was upgraded to LR-5 (definitely HCC) at contrast-enhanced ultrasound (CEUS). (A) Precontrast CT images in the liver show vague hypoattenuation in the medial left hepatic lobe (arrows). (B) Arterial phase images demonstrate no definite arterial phase hyperenhancement (arrows). (C) Washout and an enhancing capsule (arrows) on a late-phase image resulted in an LR-4 categorization. (D) B-mode ultrasound shows a round hypoechoic nodule (arrows). (E) An early-phase CEUS image shows clear arterial-phase hyperenhancement (arrows); (F) No washout at one minute (arrows), and (G) late, mild washout at four minutes (arrows) resulted in a CEUS LR-5 categorization.
PET/CT can rule out CAV in heart transplant patients
By Will Morton
Cardiac PET/CT scans can effectively rule out moderate to severe cardiac allograft vasculopathy (CAV) in heart transplant patients.
January 17, 2025
Ctca
Machine learning can predict immunotherapy response in NSCLC patients
By Kate Madden Yee
Machine learning (ML) can help clinicians predict immunotherapy response in patients with inoperable non-small cell lung cancer (NSCLC).
January 17, 2025
Lung Ct Images
Current topics in mammography
By Sandy Coffta
Sandy Coffta of Healthcare Administrative Partners discusses changes in reporting and reimbursement for mammography exams.
January 17, 2025
Coffta Sandy Thumbnail
Surgeon General's alcohol advisory puts patient counseling at the fore
By Amerigo Allegretto
Patient communication and education may be key for radiologists in the wake of the Surgeon General’s advisory on alcohol-related cancer risk.
January 17, 2025
Wine Red Glass 400
FAPI-PET shows promise for imaging gastric cancers
By Will Morton
Gallium-68 fibroblast activation protein inhibitor (FAPI) PET/CT is a promising new method for imaging gastric cancer.
January 16, 2025
Fapi Pet Gastric Cancer Thumbnail
CEM has slightly higher mean glandular dose than DBT, mammography
By Amerigo Allegretto
Contrast-enhanced mammography (CEM) has a slightly higher mean glandular dose than other breast imaging modalities.
January 16, 2025
Contrast Injector
ACS: Cancer mortality continues to drop
By Kate Madden Yee
Cancer mortality rates continue to drop -- although incidence of the disease is rising in women, according to an annual study released by the ACS.
January 16, 2025
Cancer Cell Target2
POCUS useful for diagnosis of retained conception tissue
By Amerigo Allegretto
Point-of-care ultrasound (POCUS) can be a useful tool for diagnosing the presence of retained conception tissue.
January 15, 2025
Ultrasound Portable
Top 5 predictions for the imaging IT and AI markets in 2025
By Amy Thompson
Amy Thompson of Signify Research shares five predictions for the Imaging IT and AI markets in a new column.
January 15, 2025
2025 Trends Concept
Simulated contrast-enhanced MRI helps assess prostate cancer
By Kate Madden Yee
Simulated contrast-enhanced MR images from noncontrast sequences using deep learning show promise for assessing clinically significant prostate cancer.
January 15, 2025
2025 01 14 Radiology Huang Figure5 Thumbnail
Page 1 of 111
Next Page